Related Experiment Video

Updated: Aug 19, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Intramuscular triamcinolone for difficult asthma

Jayachandran R Panickar1, Priti Kenia, Michael Silverman

  • 1Leicester Children's Asthma Centre, Department of Child Health, University of Leicester, Leicester, UK.

Pediatric Pulmonology
|January 25, 2005
PubMed

Insights

Intramuscular triamcinolone acetonide injections effectively reduced asthma exacerbations and hospital admissions in children with difficult asthma. Multiple doses showed significant benefits in both treatment and follow-up periods.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Difficult asthma in children presents significant management challenges.
  • Intramuscular corticosteroids are an option for managing severe asthma exacerbations.

Purpose of the Study:

  • To evaluate the effectiveness of intramuscular triamcinolone acetonide in reducing asthma severity markers in children.
  • To compare asthma severity markers during treatment and follow-up periods with pre-treatment levels.

Main Methods:

  • Retrospective review of asthma severity markers in children treated with intramuscular triamcinolone acetonide.
  • Comparison of pretreatment, treatment, and follow-up periods using paired t-tests.
  • Analysis of outcomes for single-dose versus multiple-dose regimens.

Main Results:

  • Multiple doses of triamcinolone acetonide significantly reduced asthma exacerbations (P < 0.01) and hospital admissions (P < 0.01).
  • A single dose reduced exacerbations (P < 0.05) but did not significantly impact hospital admissions.
  • Benefits were observed during both the treatment and follow-up periods.

Conclusions:

  • Intramuscular triamcinolone acetonide is a valuable short-term therapeutic option for difficult pediatric asthma.
  • Further research is needed to clarify if efficacy stems from improved compliance or a superior anti-inflammatory profile compared to oral steroids.

More Related Videos

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.